<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Weight management</title>
            <link>https://medicalxpress.com/overweight-obesity-news/</link>
            <language>en-us</language> 
            <description>Latest health news and information about Weight Management</description>

                            <item>
                    <title>Overweight and obesity in childhood associated with increased risk of childlessness in adulthood</title>
                    <description>A study of nearly 61,000 women in Denmark finds that women who had a body mass index (BMI) trajectory in the overweight or obesity range during childhood were less likely to have children than women with a normal (average) BMI trajectory. This effect on childlessness was already apparent in their mid-20s. The study is published in JAMA Network Open.</description>
                    <link>https://medicalxpress.com/news/2026-08-overweight-obesity-childhood-childlessness-adulthood.html</link>
                    <category></category>
                    <pubDate>Tue, 04 Aug 2026 11:00:10 EDT</pubDate>
                    <guid isPermaLink="false">news705059609</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/bmi.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Doravirine works as well as dolutegravir to suppress HIV viral load, study finds</title>
                    <description>If you&#039;re a Black, 34-year-old South African woman living with HIV, antiretroviral (ARV) treatment options have likely been limited to tenofovir disoproxil fumarate (TDF), lamivudine (3TC) and the &quot;gold standard,&quot; dolutegravir (DTG). Now, another once-daily, three-drug regimen has been found to be as effective as DTG in suppressing HIV viral load.</description>
                    <link>https://medicalxpress.com/news/2026-08-doravirine-dolutegravir-suppress-hiv-viral.html</link>
                    <category></category>
                    <pubDate>Mon, 03 Aug 2026 12:00:04 EDT</pubDate>
                    <guid isPermaLink="false">news704977021</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/study-finds-doravirine.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Not all exercise is equal when it comes to metabolic syndrome risk</title>
                    <description>Not every disease announces itself with obvious symptoms. Some develop quietly, going unnoticed until they begin to take a serious toll on health. Metabolic syndrome (MetS) is one of them. Rather than a single disease, it is a combination of at least three conditions—including high blood pressure, high blood sugar, excess belly fat, high triglycerides and low HDL (good) cholesterol—that together raise the risk of heart disease, stroke and type 2 diabetes.</description>
                    <link>https://medicalxpress.com/news/2026-07-equal-metabolic-syndrome.html</link>
                    <category></category>
                    <pubDate>Fri, 31 Jul 2026 12:40:06 EDT</pubDate>
                    <guid isPermaLink="false">news704696757</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/not-all-exercise-is-eq-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Newly discovered microprotein linked to type 2 diabetes, shows promise as a precision treatment</title>
                    <description>A previously unknown microprotein hidden within the human mitochondrial genome may help explain certain forms of type 2 diabetes and could point toward a new precision medicine approach to treating it, according to a new USC study.</description>
                    <link>https://medicalxpress.com/news/2026-07-newly-microprotein-linked-diabetes-precision.html</link>
                    <category></category>
                    <pubDate>Thu, 30 Jul 2026 15:20:06 EDT</pubDate>
                    <guid isPermaLink="false">news704642701</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/newly-discovered-micro-3.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Circadian gene variants offer new indicator of obesity risk in children</title>
                    <description>New research from the Guelph Family Health Study (GFHS) has found that circadian rhythm-related genes could influence the risk of obesity in children, highlighting an important connection between sleep and eating behavior.</description>
                    <link>https://medicalxpress.com/news/2026-07-circadian-gene-variants-indicator-obesity.html</link>
                    <category></category>
                    <pubDate>Tue, 28 Jul 2026 18:00:02 EDT</pubDate>
                    <guid isPermaLink="false">news704469902</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/child-with-soda.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>GLP-1 drugs may hold few benefits beyond physical health, study finds</title>
                    <description>GLP-1 medications such as Ozempic have transformed the treatment of type 2 diabetes, helping millions of patients better control their blood sugar while reducing cardiovascular risk and, for many, promoting substantial weight loss.</description>
                    <link>https://medicalxpress.com/news/2026-07-glp-drugs-benefits-physical-health.html</link>
                    <category></category>
                    <pubDate>Tue, 28 Jul 2026 14:20:04 EDT</pubDate>
                    <guid isPermaLink="false">news704463721</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/ozempic-4.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Different GLP-1 therapies could be tailored to patients&#039; individual metabolic needs</title>
                    <description>Different varieties and doses of GLP-1 medications can have meaningful differences in how they address heart and metabolic health issues, according to new research led by the Perelman School of Medicine at the University of Pennsylvania. Through an analysis of data from 19 randomized controlled trials, the researchers believe their work points to possible precision medicine applications of GLP-1s beyond weight loss. Their work is published in Diabetes, Obesity, and Metabolism.</description>
                    <link>https://medicalxpress.com/news/2026-07-glp-therapies-tailored-patients-individual.html</link>
                    <category></category>
                    <pubDate>Mon, 27 Jul 2026 16:20:08 EDT</pubDate>
                    <guid isPermaLink="false">news704386441</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/glp-1-medications.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Pediatric offices deliver family-based obesity treatment with lasting benefits, trial finds</title>
                    <description>Childhood obesity affects 1 in 5 children in the U.S., yet most families have limited access to specialized weight-management programs for children. Now, a large clinical trial led by researchers at Washington University School of Medicine in St. Louis, the University of Rochester Medical Center, the LSU Pennington Biomedical Research Center and the American Academy of Pediatrics (AAP) has shown that an effective, family-based treatment model can be delivered in primary care settings to treat children and adolescents with obesity.</description>
                    <link>https://medicalxpress.com/news/2026-07-pediatric-offices-family-based-obesity.html</link>
                    <category></category>
                    <pubDate>Mon, 27 Jul 2026 11:00:08 EDT</pubDate>
                    <guid isPermaLink="false">news704105173</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/overweight-child.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Biomarker discovery could advance treatments for obesity-related health risks</title>
                    <description>Researchers have identified a biological marker that rises and falls as body fat changes, offering new insight into how weight gain and weight loss may influence metabolic health.</description>
                    <link>https://medicalxpress.com/news/2026-07-biomarker-discovery-advance-treatments-obesity.html</link>
                    <category></category>
                    <pubDate>Fri, 24 Jul 2026 11:20:06 EDT</pubDate>
                    <guid isPermaLink="false">news704109781</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/biomarker-discovery-co-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Distinct brain circuits explain contradictory behaviors of new weight-loss drugs</title>
                    <description>Cambridge scientists have solved the mystery of why both stimulating and blocking a particular &quot;switch&quot; in the brain can help people lose weight—findings that could help boost the effectiveness of obesity drugs.</description>
                    <link>https://medicalxpress.com/news/2026-07-distinct-brain-circuits-contradictory-behaviors.html</link>
                    <category></category>
                    <pubDate>Fri, 24 Jul 2026 05:00:06 EDT</pubDate>
                    <guid isPermaLink="false">news704044861</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/brain-regions.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Breathalyzer can &#039;sniff out&#039; when your body starts burning fat</title>
                    <description>Researchers have developed a breath detector with a chemical sensor that sniffs out when your body is burning fat through a single exhale. Reporting in  Device, the handheld, smartphone-assisted device measures acetone—a molecule that is released into the breath when the body burns fat—in about 90 seconds with laboratory-level accuracy.</description>
                    <link>https://medicalxpress.com/news/2026-07-breathalyzer-body-fat.html</link>
                    <category></category>
                    <pubDate>Wed, 22 Jul 2026 11:00:05 EDT</pubDate>
                    <guid isPermaLink="false">news703841521</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/breathalyzer-that-snif.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Semaglutide sustains lower calorie intake for more than a year, study shows</title>
                    <description>People taking semaglutide for weight loss continued to consume significantly fewer calories after 60 weeks on the medication, helping explain how the medication supports both initial weight loss and long-term weight maintenance. The study, published in the American Journal of Clinical Nutrition and led by investigators from Penn&#039;s Center for Weight and Eating Disorders and Penn Metabolic Medicine, is among the first to examine the long-term effects of semaglutide on eating behavior beyond the initial months of treatment.</description>
                    <link>https://medicalxpress.com/news/2026-07-semaglutide-sustains-calorie-intake-year.html</link>
                    <category></category>
                    <pubDate>Tue, 21 Jul 2026 15:40:02 EDT</pubDate>
                    <guid isPermaLink="false">news703857028</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/dieting-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>It&#039;s not just fat: Yo-yo dieting might mean losing muscle, too</title>
                    <description>Repeatedly losing and gaining weight may do more than frustrate dieters—it also accelerates muscle loss in middle-aged people, according to new UC San Francisco research that comes as weight-loss medications transform obesity treatment.</description>
                    <link>https://medicalxpress.com/news/2026-07-fat-yo-dieting-muscle.html</link>
                    <category></category>
                    <pubDate>Tue, 21 Jul 2026 13:00:03 EDT</pubDate>
                    <guid isPermaLink="false">news703855321</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/its-not-just-fat-yo-yo.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>GLP-1 use rising rapidly among US adolescents and young adults, study finds</title>
                    <description>Adolescents and young adults in the U.S. are increasingly using popular GLP-1 weight-loss drugs alone or in conjunction with metabolic and bariatric surgery (MBS) to manage obesity, according to a study by UT Southwestern Medical Center researchers published in JAMA Pediatrics.</description>
                    <link>https://medicalxpress.com/news/2026-07-glp-rapidly-adolescents-young-adults.html</link>
                    <category></category>
                    <pubDate>Mon, 20 Jul 2026 15:40:06 EDT</pubDate>
                    <guid isPermaLink="false">news703778101</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/ozempic-5.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New body index aims to move beyond BMI and works for babies too</title>
                    <description>Body Mass Index (BMI) has long been used in public health and clinical settings as a simple tool to classify an individual&#039;s physical status based on their height and weight. Originally developed in the 1830s by Belgian mathematician Adolphe Quetelet, BMI was designed to describe the characteristics of the average man rather than to assess an individual&#039;s health, and it did not account for age, sex, ethnicity or body composition.</description>
                    <link>https://medicalxpress.com/news/2026-07-body-index-aims-bmi-babies.html</link>
                    <category></category>
                    <pubDate>Fri, 17 Jul 2026 07:50:02 EDT</pubDate>
                    <guid isPermaLink="false">news703491612</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/new-body-index-aims-to.jpg" width="90" height="90" />
                                    </item>
                    </channel>
</rss>
